Enzyme replacement therapy with imiglucerase in Taiwanese patients with type I Gaucher disease

Journal of the Formosan Medical Association

Volumn 101, Issue 9, 2002, Pages 627-631

  Hsu, Chia Chi ^b   Chien, Yin Hsiu ^a   Lai, Ming Yang ^a   Hwu, Wuh Liang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Enzyme replacement therapy; Gaucher disease; Imiglucerase

Indexed keywords

ALANINE AMINOTRANSFERASE; ALGLUCERASE; ALKALINE PHOSPHATASE; ANTIHISTAMINIC AGENT; ASPARTATE AMINOTRANSFERASE; GLUCOSYLCERAMIDASE; HEMOGLOBIN; IMIGLUCERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE PAIN; BONE RADIOGRAPHY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG COST; ENZYME REPLACEMENT; FEMALE; FLUSHING; GAUCHER DISEASE; HEALTH CARE COST; HEMOGLOBIN DETERMINATION; HUMAN; LABORATORY TEST; LIVER FUNCTION; LIVER SIZE; MALE; PHYSICAL EXAMINATION; PRURITUS; QUALITY OF LIFE; SPLENECTOMY; TAIWAN; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; URTICARIA;

ADULT; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 0036767645     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Pastores GM, Einhorn TA: Skeletal complications of Gauchers disease: pathophysiology, evaluation, and treatment. Semin Hematol 1995;32(3 Suppl 1):20-7.
2. Barranger JA, Rice E: An overview of Gaucher disease. Gaucher Clinical Perspectives 1993;1:1-5.
3. Grabowski GA, Barton NW, Pastores G, et al: Enzyme therapy in type I Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Intern Med 1995;122:33-9.
4. Rappeport JM, Ginns E: Bone-marrow transplantation in severe Gaucher disease. N Engl J Med 1984;311:84-8.
5. Pastores GM, Sibille AR, Grabowski GA: Enzyme therapy in Gaucher disease type I: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months. Blood 1993;82:408-16.
6. Beutler E, Kay A, Saven A, et al: Enzyme replacement therapy for Gaucher disease. Blood 1991;78:1183-9.
7. Barton NW, Rosenthal DI, Mankin HJ, et al: Skeletal responses to enzyme replacement therapy in patients with Gaucher disease: what are the goals and expectations of treatment? Gaucher Clinical Perspectives 1996;4:2-7.
8. Parker RI, Barton NM, Read EJ, et al: Hematologic improvement in a patient with Gaucher disease on long-term enzyme replacement therapy:evidence for decreased splenic sequestration and improved red blood cell survival. Am J Hematol 1991;38:130-7.
9. Zimran A, Elstein D, Kannai R, et al: Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment. Am J Med 1994;97:3-13.
10. Verderese CL, Graham OC, Holder-McShane CA, et al: Gaucher disease: a pilot study of the symptomatic responses to enzyme replacement therapy. J Neurosci Nurs 1993;25:296-301.
11. Gaucher disease. Current issues in diagnosis and treatment. NIH Technology Assessment Panel on Gaucher Disease. JAMA 1996;275:548-53.
12. Beutler E, Grabowski GA: Gaucher disease. In: Scriver CR, Childs B, Kinzler KW, et al, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001:3635-68.
13. Moscicki R, Kingma W: The safety of Ceredase therapy in Gaucher disease: adverse effects and immune responses. Gaucher Clinical Perspectives 1994;2:7-11.